According to our current understanding of the universe, quarks are fundamental, point-like particles: basic building blocks ...
As a company, Fluke has been making electronic test equipment longer than the bipolar junction transistor has been around for ...
A few engineers and innovators share details about practical test and measurement habits that save time and help avoid poor ...
Your home devices and appliances quietly suck energy even when not in active use. I found the worst offender and it totally shocked me. Alan Bradley is an experienced commerce, tech and culture writer ...
CAMBRIDGE, England, March 17, 2026 /PRNewswire/ -- Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, ...
CAMBRIA COUNTY, Pa. – (WJAC) No injuries were reported following an early morning house fire in Johnstown.According to Cambria County emergency officials, the f One person transported after ...
Add Yahoo as a preferred source to see more of our stories on Google. FMCSA increasing pressure on foreign drivers using English language testing. (Photo: Jim Allen/FreightWaves) WASHINGTON — The U.S.
A blood test which looks for multiple types of cancer has failed to achieve its key objective in a major NHS trial, the company has announced. The Galleri blood test is being trialled on 142,000 NHS ...
A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage ...
Just weeks after filing for FDA approval of its Galleri blood test for cancer screening, Grail has reported that a flagship trial of the technology in the UK failed to achieve its primary objective.
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...